These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36504336)

  • 21. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons.
    McLean HQ; Thompson MG; Sundaram ME; Meece JK; McClure DL; Friedrich TC; Belongia EA
    Clin Infect Dis; 2014 Nov; 59(10):1375-85. PubMed ID: 25270645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza Vaccine Effectiveness Among Children: 2011-2020.
    Hood N; Flannery B; Gaglani M; Beeram M; Wernli K; Jackson ML; Martin ET; Monto AS; Zimmerman R; Raviotta J; Belongia EA; McLean HQ; Kim S; Patel MM; Chung JR
    Pediatrics; 2023 Apr; 151(4):. PubMed ID: 36960655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of the 2019-2020 Influenza Vaccine and the Effect of Prior Influenza Infection and Vaccination in Children during the First Influenza Season Overlapping with the COVID-19 Epidemic.
    Ando S
    J Nippon Med Sch; 2021 Dec; 88(6):524-532. PubMed ID: 33692300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023.
    McLean HQ; Petrie JG; Hanson KE; Meece JK; Rolfes MA; Sylvester GC; Neumann G; Kawaoka Y; Belongia EA
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(8):201-205. PubMed ID: 36821715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016.
    Feldstein LR; Ogokeh C; Rha B; Weinberg GA; Staat MA; Selvarangan R; Halasa NB; Englund JA; Boom JA; Azimi PH; Szilagyi PG; McNeal M; Harrison CJ; Williams JV; Klein EJ; Sahni LC; Singer MN; Lively JY; Payne DC; Fry AM; Patel M; Campbell AP
    J Pediatric Infect Dis Soc; 2021 Mar; 10(2):75-82. PubMed ID: 32108879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.
    Flannery B; Chung JR; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Foust A; Sessions W; Berman L; Barnes JR; Spencer S; Fry AM
    MMWR Morb Mortal Wkly Rep; 2018 Feb; 67(6):180-185. PubMed ID: 29447141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016.
    Balasubramani GK; Nowalk MP; Sax TM; Suyama J; Bobyock E; Rinaldo CR; Martin ET; Monto AS; Jackson ML; Gaglani MJ; Flannery B; Chung JR; Zimmerman RK
    Influenza Other Respir Viruses; 2020 Jul; 14(4):380-390. PubMed ID: 32298048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
    Doyle JD; Chung JR; Kim SS; Gaglani M; Raiyani C; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Foust A; Sessions W; Berman L; Garten RJ; Barnes JR; Wentworth DE; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(6):135-139. PubMed ID: 30763298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS-CoV-2 during the 2021-2022 season in Bulgaria.
    Korsun N; Trifonova I; Dobrinov V; Madzharova I; Grigorova I; Christova I
    J Med Virol; 2023 Feb; 95(2):e28489. PubMed ID: 36832544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China.
    Zhang L; Pan Y; Ma C; Duan W; Sun Y; Wu S; Zhang M; Tian Y; Zheng Y; Yang P; Wang Q
    Hum Vaccin Immunother; 2018 Jun; 14(6):1323-1330. PubMed ID: 29461909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018.
    Tenforde MW; Chung J; Smith ER; Talbot HK; Trabue CH; Zimmerman RK; Silveira FP; Gaglani M; Murthy K; Monto AS; Martin ET; McLean HQ; Belongia EA; Jackson LA; Jackson ML; Ferdinands JM; Flannery B; Patel MM
    Clin Infect Dis; 2021 Aug; 73(3):386-392. PubMed ID: 32270198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated With B/Victoria Viruses, 2019-2020.
    Campbell AP; Ogokeh C; Weinberg GA; Boom JA; Englund JA; Williams JV; Halasa NB; Selvarangan R; Staat MA; Klein EJ; McNeal M; Michaels MG; Sahni LC; Stewart LS; Szilagyi PG; Harrison CJ; Lively JY; Rha B; Patel M;
    Clin Infect Dis; 2021 Aug; 73(4):e947-e954. PubMed ID: 33502489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
    Flannery B; Zimmerman RK; Gubareva LV; Garten RJ; Chung JR; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Ohmit SE; Belongia EA; McLean HQ; Gaglani M; Piedra PA; Mishin VP; Chesnokov AP; Spencer S; Thaker SN; Barnes JR; Foust A; Sessions W; Xu X; Katz J; Fry AM
    J Infect Dis; 2016 Oct; 214(7):1010-9. PubMed ID: 27190176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
    Kissling E; Pozo F; Buda S; Vilcu AM; Gherasim A; Brytting M; Domegan L; Gómez V; Meijer A; Lazar M; Vučina VV; Dürrwald R; van der Werf S; Larrauri A; Enkirch T; O'Donnell J; Guiomar R; Hooiveld M; Petrović G; Stoian E; Penttinen P; Valenciano M;
    Euro Surveill; 2019 Nov; 24(48):. PubMed ID: 31796152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
    McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
    JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
    Kim S; Chuang ES; Sabaiduc S; Olsha R; Kaweski SE; Zelyas N; Gubbay JB; Jassem AN; Charest H; De Serres G; Dickinson JA; Skowronski DM
    Euro Surveill; 2022 Sep; 27(38):. PubMed ID: 36148674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation.
    Sominina A; Danilenko D; Komissarov AB; Pisareva M; Fadeev A; Konovalova N; Eropkin M; Petrova P; Zheltukhina A; Musaeva T; Eder V; Ivanova A; Komissarova K; Stolyarov K; Karpova L; Smorodintseva E; Dorosh A; Krivitskaya V; Kuznetzova E; Majorova V; Petrova E; Boyarintseva A; Ksenafontov A; Shtro A; Nikolaeva J; Bakaev M; Burtseva E; Lioznov D
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.